Passage Bio, Inc.
PASG
$4.59
$0.020.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 50.93% | -2.03% | 59.93% | 41.31% | 7.82% |
| Total Depreciation and Amortization | -35.82% | -75.38% | -76.15% | -78.80% | -75.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -102.12% | 366.78% | -89.42% | -45.49% | 214.86% |
| Change in Net Operating Assets | -141.73% | -17.54% | -60.75% | 474.93% | 45.70% |
| Cash from Operations | 6.21% | 23.27% | 34.83% | 51.81% | 26.85% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -96.58% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -100.00% | -100.00% | 54.63% |
| Cash from Investing | -99.95% | -100.00% | -100.00% | -44.18% | 56.95% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -80.85% | -- | -83.53% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -80.85% | -- | -83.53% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -150.29% | -222.51% | -164.52% | 52.25% | 71.16% |